Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001019687-10-003991)

Filing Details

Accession Number:: 0001019687-10-003991
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-11-09 19:10:36
Reporting Period:: 2010-11-08

Filing Date:: 2010-11-09
Accepted Time:: 2010-11-09 19:10:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
704562	Peregrine Pharmaceuticals Inc	PPHM	In Vitro & In Vivo Diagnostic Substances (2835)	953698422

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1244108	S Eric Swartz	C/O Peregrine Pharmaceuticals, Inc. 14282 Franklin Avenue Tustin, CA 92780		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $.001 Par Value	Acquisiton	2010-11-08	1,600	$1.58	101,600	No	4	P	Indirect	By Highlight Fund, LLC
Common Stock, $.001 Par Value	Acquisiton	2010-11-08	8,400	$1.60	110,000	No	4	P	Indirect	By Highlight Fund, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Highlight Fund, LLC
No	4	P	Indirect	By Highlight Fund, LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $.001 Par Value	438,379	Direct
Common Stock, $.001 Par Value	107,739	Indirect	By Swartz Ventures, Inc.

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Non-Qualified Stock Option (right to buy)	$0.00			440,000	440,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	440,000	440,000	Direct

Footnotes

Includes 52,978 shares held in an Individual Retirement Account (IRA) for the benefit of Eric S. Swartz.
Not applicable.